Sun Pharma Corporate Overview

Research & Development Cumulative R&D Spend of over Rs. 193 billion to date • R&D Spend • Capabilities Organization IPR Support • Focus © Sun Pharmaceutical Industries Limited. All Rights Reserved. • R&D spend at 6.5 % of sales for FY21 Strong cash flows & large scale to support R&D investments Capabilities in generics, finished dosage development, biological support, chemistry and new drug development • Approx. 2,600 headcount globally with capabilities across dosage forms like orals, liquids, ointments, gels, sprays, injectables Strong team of intellectual property experts supporting R&D • Developing non infringing formulations and development of specialty/complex products SUN PHARMA 36

View entire presentation